NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/29/2025
Back to search
Official data from USPTO
1 EUEAL BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
07/29/2025
Trademark type
Combined
Nice classes
5
Filing date
05/27/2022
Registration date
07/29/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/29/2025
Last transaction
07/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-00-00
First use in commerce
2023-00-00
Drawing code
5
Owner type
03
Owner location
Chungcheongbuk-do, KR
Examiner
SALES, HEATHER ALISON
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "EUEAL" in bold font, followed by the wording "BIOTECH" below. To the left of these wordings is a design that looks like a large stylized number "1".
Holders and representatives
Holders
N-CELL CO., LTD.
Representatives
SANG HO LEE BRIDGEWAY IP LAW GROUP, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nutraceutical preparations for therapeutic and medical purposes for prevention and treatment of cancercardiovascular diseaseshypertensionatherosclerosisischemiaaneurysmsictusinfarctionanginastrokecerebrovascular accidentsneurodegenerative diseasesAlzheimer's diseaseParkinson's diseasemultiple sclerosisamyotrophic lateral sclerosis (ALS)sclerosis of the hippocampusepilepsyfocal sclerosisadrenoleukodystrophyleukodystrophyvascular dementiasenile dementiaheadachesmigraine headachescentral nervous system traumasleep disordersdizzinesspaindepressionanxietydrug and alcohol addictionsblindnesshearing problemsdisorientationaltered moodobesityoverweightnessmetabolic disordershypercholesterolemiahypertriglyceridemiahyperglycaemiadiabetesinflammatory diseasesinfectious diseasesautoimmune diseases; pharmaceutical preparations for the prevention of diseases in the immune system; health food supplements; crude medicinesmedicines for treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; dietary supplemental nutritive substances being dietary supplements; nutraceuticals for use as a dietary supplement; dietetic preparations adapted for medical purposesdietetic food supplements; dietary and nutritionally fortified food being dietetic foods adapted for medical purposes; food supplements for medical purposes; nutritionally fortified beverages for medical purposes; none of the foregoing containing ingredients from the cannabis sativa L plant or its extracts
Publications
History of USPTO decisions and trademark events.
58 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/29/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/16/2025
EXPT
EXPARTE APPEAL TERMINATED
07/05/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/05/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
07/01/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/01/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
07/01/2025
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
07/01/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
06/10/2025
EXPI
EX PARTE APPEAL-INSTITUTED
04/04/2025
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
04/04/2025
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
01/18/2025
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
01/18/2025
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
01/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/06/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
01/06/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
01/06/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/04/2024
GNFR
FINAL REFUSAL E-MAILED
10/04/2024
CNFR
SU - FINAL REFUSAL - WRITTEN
10/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/29/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/29/2024
ALIE
ASSIGNED TO LIE
09/29/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/02/2024
GNRT
NON-FINAL ACTION E-MAILED
03/02/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/02/2024
DOCK
ASSIGNED TO EXAMINER
02/28/2024
DOCK
ASSIGNED TO EXAMINER
02/26/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/21/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/21/2024
IUAF
USE AMENDMENT FILED
01/30/2024
EISU
TEAS STATEMENT OF USE RECEIVED
01/30/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/08/2023
PUBO
PUBLISHED FOR OPPOSITION
08/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/19/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/03/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/26/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/26/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/26/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/21/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/21/2023
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
03/21/2023
GPRA
PRIORITY ACTION E-MAILED
03/21/2023
CPRA
PRIORITY ACTION WRITTEN
03/21/2023
DOCK
ASSIGNED TO EXAMINER
03/15/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/04/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/04/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2022
NWAP
NEW APPLICATION ENTERED
05/31/2022
Continuous trademark protection
Get notified about every new filing that threatens 1 EUEAL BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.